Baxter International continues to underperform Gilead by 3.9% in the past three months

Media coverage

• Title	Baxter International continues to underperform Gilead by 3.9% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	3/31/25
  Persons	Robert P. Smith

• Title	Baxter International continues to outperform Alnylam Pharmaceuticals by 4.7% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	3/31/25
  Persons	Robert P. Smith

• Title	Baxter International continues to outperform Regeneron by 27.7% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	3/31/25
  Persons	Robert P. Smith

• Title	Baxter International continues to underperform Amgen by 0.9% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	3/31/25
  Persons	Robert P. Smith